Literature DB >> 3104047

Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.

A Creutzig, H Creutzig, K Alexander.   

Abstract

The effects of intraarterially administered prostaglandin E1 (PGE1) on macrocirculatory, microcirculatory and metabolic parameters in patients with peripheral arterial occlusive disease were studied. Nutritive calf muscle blood flow, as determined with the xenon-clearance technique, and muscle tissue oxygen pressure increased markedly in patients with obliterations of the femoral artery. Transcutaneous PO2 as indicator for cutaneous blood flow increased in prestenotic regions dose-dependently whereas there was a clear poststenotic decrease during the infusion period. High lactate/pyruvate ratios in the femoral vein were significantly decreased by PGE1 treatment. PO2 in the femoral vein increased significantly. Thus, PGE1 has some beneficial effects on muscle circulation in these patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3104047     DOI: 10.1111/j.1365-2362.1986.tb02165.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Clinical effects of intravenous iloprost in patients with intermittent claudication.

Authors:  U Müller-Bühl; C Diehm; T Krais; R Zimmermann; H Mörl; H H Eckstein
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.

Authors:  A Creutzig; L Caspary; K Alexander
Journal:  Klin Wochenschr       Date:  1990-02-15

3.  The effect of prostaglandin E1 on brainstem blood flow disturbance in an animal model of vertebrobasilar insufficiency.

Authors:  Toshiaki Yamanaka; Takayuki Murai; Yachiyo Sawai; Hideyuki Okamoto; Hiroshi Hosoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.